News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Intercell AG And Statens Serum Institut (SSI) Sign Cooperation And License


10/19/2005 5:10:29 PM

Intercell AG and Statens Serum Institut (SSI) today announced the signature of a commercial license agreement for the development of a new prophylactic tuberculosis vaccine.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES